CanCOVID is a Canadian health research initiative formed in April 2020 by Innovation, Science and Economic Development Canada (ISED) and Chief Scientific Advisor Dr. Mona Nemer.
Affiliations
CanCOVID is partnered with Covid Trials Canada.[1]
Funding
CanCOVID is funded by the Government of Canada through Innovation, Science and Economic Development Canada.[2] Various CanCOVID research projects were funded by the McGill Interdisciplinary Initiative in Infection and Immunity (MI4).[3]
Team
CanCOVID is led by Peter Jüni, Nathan Stall, Susan Law, and Karim Keshavjee.[4] Vivek Goel is a former Network Science Advisor.
External links
About. Covid Trials Canada. Retrieved May 20, 2020, from https://web.archive.org/web/20200520142316/https://covidtrials.ca/about ↩︎
Innovation, Science and Economic Development Canada. (2022, February 1). 2020–21 Departmental Results Report. Government of Canada. https://web.archive.org/web/20220518195246/https://ised-isde.canada.ca/site/planning-performance-reporting/en/departmental-results-reports/departmental-results-report-2020-21departmental-results-reports/departmental-results-report-2019-20/2020-21-departmental-results-report ↩︎
Results of MI4 Emergency COVID-19 Research Funding. MI4. Retrieved May 16, 2023, from https://web.archive.org/web/20230516234033/https://www.mcgill.ca/mi4/mi4-supported-research/emergency-covid-19-research-funding ↩︎
About. CanCOVID. Retrieved April 24, 2022, from http://archive.today/2021.12.31-111351/https://cancovid.ca/about/ ↩︎
